BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38180299)

  • 21. FGF7 Over Expression is an Independent Prognosticator in Patients with Urothelial Carcinoma of the Upper Urinary Tract and Bladder.
    Fan EW; Li CC; Wu WJ; Huang CN; Li WM; Ke HL; Yeh HC; Wu TF; Liang PI; Ma LJ; Li CF
    J Urol; 2015 Jul; 194(1):223-9. PubMed ID: 25623741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High MT2A Expression Predicts Worse Prognosis in Patients with Urothelial Carcinoma.
    Li WM; Ke HL; Kuo YH; Lai HY; Chan TC; Hsing CH; Hsieh KL; Li WS; Chen TJ; Wei YC; Wu WJ; Huang SK; Li CF
    Oncology; 2022; 100(9):485-497. PubMed ID: 35817020
    [No Abstract]   [Full Text] [Related]  

  • 23. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ANXA10 Expression Is Inversely Associated with Tumor Stage, Grade, and TP53 Expression in Upper and Lower Urothelial Carcinoma.
    Kobayashi G; Hayashi T; Sentani K; Ikeda K; Babasaki T; Shigematsu Y; Sekino Y; Uraoka N; Teishima J; Matsubara A; Hinata N; Oue N
    Pathobiology; 2023; 90(2):94-103. PubMed ID: 35780773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Programmed Death-ligand 1 Expression in Upper Tract Urothelial Carcinoma.
    Skala SL; Liu TY; Udager AM; Weizer AZ; Montgomery JS; Palapattu GS; Siddiqui J; Cao X; Fields K; Abugharib AE; Soliman M; Hafez KS; Miller D; Lee CT; Alva A; Chinnaiyan AM; Morgan TM; Spratt DE; Jiang H; Mehra R
    Eur Urol Focus; 2017 Oct; 3(4-5):502-509. PubMed ID: 28753826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic Interference of FGFR3 Impedes Invasion of Upper Tract Urothelial Carcinoma Cells by Alleviating RAS/MAPK Signal Activity.
    Huang GK; Huang CC; Kang CH; Cheng YT; Tsai PC; Kao YH; Chung YH
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological characteristics and outcomes of synchronous renal cell carcinoma and urothelial carcinoma: A population-based analysis.
    Wu K; Liu X; Wang Y; Wang X; Li X
    Front Public Health; 2022; 10():994351. PubMed ID: 36388369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of upper tract urothelial carcinoma on response to BCG in patients with non-muscle-invasive bladder cancer.
    Bree KK; Hensley PJ; Brooks NA; Matulay J; Li R; Nogueras Gonzalez GM; Navai N; Grossman HB; Matin SF; Dinney CPN; Kamat AM
    BJU Int; 2021 Nov; 128(5):568-574. PubMed ID: 33484074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma.
    Li CF; Chan TC; Pan CT; Vejvisithsakul PP; Lai JC; Chen SY; Hsu YW; Shiao MS; Shiue YL
    Cell Oncol (Dordr); 2021 Oct; 44(5):1133-1150. PubMed ID: 34339014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Higher risk of urothelial carcinoma in the upper urinary tract than in the urinary bladder in hemodialysis patients.
    Hsiao PJ; Hsieh PF; Chang CH; Wu HC; Yang CR; Huang CP
    Ren Fail; 2016 Jun; 38(5):663-70. PubMed ID: 26956094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms on 8q24.1 and 4p16.3 are not linked with urothelial carcinoma of the bladder in contrast to their association with aggressive upper urinary tract tumours.
    Yates DR; Rouprêt M; Drouin SJ; Audouin M; Cancel-Tassin G; Comperat E; Bitker MO; Cussenot O
    World J Urol; 2013 Feb; 31(1):53-9. PubMed ID: 23053209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and demographic characteristics among patients with urothelial carcinomas of the upper urinary tract and bladder in Taiwan.
    Shen CH; Chiou HY; Tung MC; Wu CC; Kao WT; Wang YH; Juang GD
    J Chin Med Assoc; 2017 Sep; 80(9):563-568. PubMed ID: 28751166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of female non-muscle-invasive bladder cancer in Taiwan: association with upper tract urothelial carcinoma and end-stage renal disease.
    Chen CH; Shun CT; Huang KH; Huang CY; Yu HJ; Pu YS
    Urology; 2008 Jun; 71(6):1155-60. PubMed ID: 18372011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.
    Ma LJ; Wu WJ; Wang YH; Wu TF; Liang PI; Chang IW; He HL; Li CF
    J Cancer; 2016; 7(4):467-76. PubMed ID: 26918061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review.
    van Doeveren T; van de Werken HJG; van Riet J; Aben KKH; van Leeuwen PJ; Zwarthoff EC; Boormans JL
    Urol Oncol; 2020 Jun; 38(6):590-598. PubMed ID: 32057596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
    Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
    J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper Urinary Tract Tumors: Variant Histology Versus Urothelial Carcinoma.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Apr; 19(2):117-124. PubMed ID: 33358490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    Li WM; Wei YC; Huang CN; Ke HL; Li CC; Yeh HC; Chang LL; Huang CH; Li CF; Wu WJ
    J Surg Oncol; 2016 May; 113(6):700-7. PubMed ID: 26861489
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global gene expression profiling identifies ALDH2, CCNE1 and SMAD3 as potential prognostic markers in upper tract urothelial carcinoma.
    Wu S; Chen J; Dong P; Zhang S; He Y; Sun L; Zhu J; Cheng Y; Li X; Tang A; Huang Y; Gui Y; Liu C; Yang G; Zhou F; Cai Z; Wang R
    BMC Cancer; 2014 Nov; 14():836. PubMed ID: 25408144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.